BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TiGenix 

Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70


SEARCH JOBS




Industry
Biotechnology






 Company News
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 2 June 2015 5/13/2015 9:48:13 AM
USPTO Issues Key US Patent To TiGenix For The Use Of Adipose-Derived Stromal Cells In The Treatment Of Fistulas 4/8/2015 9:39:10 AM
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015 7:26:11 AM
TiGenix Reports Its Full Year 2014 Results 3/17/2015 7:41:03 AM
TiGenix Completes Treatment In Phase I Sepsis Challenge Trial With Cx611 3/12/2015 7:20:06 AM
TiGenix's Phase III Trial Design For Cx601 Endorsed By President-Elect Of ECCO 2/23/2015 7:18:15 AM
TiGenix And Lonza Group Ltd. (LZAGY.PK) Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas In Crohn's Disease 2/12/2015 7:32:55 AM
TiGenix Participates In Key Conferences In The First Half Of 2015 2/2/2015 9:03:11 AM
European Patent Office Issues Key Patent To TiGenix For Expanded Adipose-Derived Stem Cell Compositions 1/22/2015 7:40:09 AM
TiGenix Submits Its Pivotal US Trial Design For Cx601 To The FDA For Special Protocol Assessment 12/22/2014 7:15:29 AM
12345678